Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Glendale Hotel and Spa

Mar 16, 2015 1:00 PM - Mar 18, 2015 4:30 PM

9495 W. Coyotes Boulevard, Glendale, AZ 85305

Medical & Scientific Communications 2015 Annual Forum

Back to Agenda

Session 8 Track E: MSLs and Customer Access – Getting Access and Demonstrating Value

Session Chair(s)

Beth Price

Beth Price

Vice President

The Medical Affairs Company, United States

Understanding the barriers and getting access to KOLs, institutions, payers, ACOs and community practices has continued to present challenges within our industry, yet MSLs have maintained their ability to demonstrate their clinical utility and value through targeted clinical data discussions and educational support activities. These activities have clearly differentiated the MSL’s and their organization’s value to these stakeholders and importantly, enabled them to engage with stakeholders and healthcare professional audiences that may be unaccessible to their commercial industry colleagues.

The first part of this session will focus on trends in access restriction and what the factors/drivers may entail including those specialties which are considered more restrictive. A unique field medical program case study will be shared and how this unique program has ensured that healthcare professional audiences within this restricted access system are receiving timely, fair-balanced, compliant and thorough clinical data educational support and services.

The second part of this session will focus on institutional access & credentialing and restricted access. Strategies and best practices for accessing customers with limited time will be discussed alongside the clinical and educational activities that MSLs can provide. Training programs and resources in support of these activities will also be shared as well as documentation and portal systems used to manage these activities.

The final component to this session will be the discussion of methods and metrics useful for demonstrating the MSL and MSL teams’ value to their organizations. Examples of specific activities aligned by stakeholder audiences will be discussed and how the MSLs established both initial and long-term value. Strategies for compliantly disseminating and vetting OL clinical insights and competitive intelligence amongst internal constituents will also be shared.

Speaker(s)

Beth Price

Faculty

Beth Price

The Medical Affairs Company, United States

Vice President

Faculty

Norm Enriquez, PharmD

The Medical Affairs Company, United States

Vice President, Business Development

David Price, PhD

Faculty

David Price, PhD

Lilly USA, LLC, United States

Advisor, US Field Medical, Bio-Medicines Medical Sciences Liaisons

Have an account?